Aug 16, 2025 at 6:56 PM#6
Both Frank and Rick make excellent points and they're not mutually exclusive. The standard panel (HPLC + ESI-MS) is:
- Sufficient for verifying identity and basic quality ✓
- Insufficient for full pharmaceutical characterization ✓
- The best available option for community-level testing given cost constraints ✓
- Not a substitute for proper pharmaceutical manufacturing controls ✓
My advice for the average person here: get the standard panel and use it to make informed decisions. If the mass spec confirms identity and HPLC shows >97% purity and correct content, you've eliminated the most common quality issues (wrong product, low purity, underfilling).
If you want to go further, the community-funded testing initiative (see the other thread) is exploring more advanced testing like SEC for aggregation. Pooling resources makes the expensive tests accessible.
For now, ESI-MS identity confirmation remains the single most important test you can get. It's the only way to conclusively prove that what's in the vial is what it claims to be. HPLC tells you purity and potency — critical information, but useless if the product isn't actually semaglutide.
31 2Dr.PainCLE, mike_mealprep, NicoleRaleigh and 28 others
Reply Quote Save Share Report